| 2025.9.9 |
A treatment strategy to mitigate the adverse effect of pretransplant mogamulizumab on post-transplant clinical outcome in patients with aggressive ATL
Fuji S, et al., Br J Haematol (2024) |
| 2025.9.9 | Inhibitory effect of a neddylation blockade on HTLV-1-infected T cells via modulation of NF-κB, AP-1, and Akt signaling
Ishikawa C, Mori N, Leuk Lymphoma (2024) |
| 2025.9.9 | Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma
Ichikawa T, et al., Int J Mol Sci (2024) |
| 2025.9.9 | Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins
Sudo H, et al., Leuk Res (2024) |
| 2025.9.9 | Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
Sato T, et al., J Neurol (2024) |
| 2025.9.9 | Purification Method of Extracellular Vesicles Derived from Human T-Cell Leukemia Virus Type 1-Infected Cells without Virions
Kawano K, et al., Viruses (2024) |
| 2025.9.9 | IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors
Wang Y, et al., Front Oncol (2024) |
| 2025.9.9 | Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan
Nozuma S, et al., PLoS Negl Trop Dis (2024) |
| 2025.9.9 | Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus
Nagata K, et al., J Virol (2024) |
| 2025.9.9 | Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma
Nakashima M, et al., Cells (2024) |
| 2025.9.9 | Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
Kameda T, et al., BMC Infect Dis (2024) |
| 2025.9.9 | Reprogramming of pyrimidine nucleotide metabolism supports vigorous cell proliferation of normal and malignant T cells
Watanabe T, et al., Blood Adv (2024) |
| 2025.9.9 | Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma
Yamada A, et al., Cancer Sci (2024) |
| 2025.9.9 | Lung Involvement in Adult T-Cell Lymphoma Diagnosed Using Bronchoscopic Cryobiopsy: A Case Report and Review of the Literature
Tanaka Y, et al., Medicina (Kaunas) (2023) |
| 2025.9.9 | Patient with Adult T-cell Leukemia and Lung Infection caused by Mycobacterium abscessus: Successful Treatment with Intensive Chemotherapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report
Azumi H, et al., Intern Med. (2023) |
| 2025.9.9 | Whole genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in Adult T-cell leukemia/lymphoma
Chiba M, et al., Blood (2023) |
| 2025.9.9 | The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility
Wang Y, Iha H., Genes (Basel) (2023) |
| 2025.9.9 | Indolent adult T-cell leukaemia-lymphoma successfully treated with bexarotene in an eldery patient
Nakashima M,et al., JEADV clin pract (2023) |
| 2025.9.9 | Impact of GVHD on lymphoma progression: Nationwide study from Japanese Society for Transplantation and Cellular Therapy
Watanabe M, et al., Br J Haematol (2023) |
| 2025.9.9 | CDK9 Inhibitor Induces Apoptosis, Autophagy, and Suppression of Tumor Growth in Adult T-Cell Leukemia/Lymphoma
Kato N, et al., Biol Pharm Bull (2023) |
| 2025.9.9 | The development of adult T cell leukemia/lymphoma in renal transplant recipients: report of two cases with literature review
Kawano N, et al., Ren Replace Ther (2023) |
| 2025.9.9 | Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report
Nagano H, et al., Indian J Otolaryngol Head Neck Surg (2023) |
| 2025.9.9 | Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
Matsuura E, et al., Pathogens (2023) |
| 2025.9.9 | Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion
Maeda Y, et al., Int J Mol Sci (2023) |
| 2025.9.9 | Serum Calcium Level and Functional Atherosclerosis in Relation to Human T-Cell Leukemia Virus 1 Infection in Older Individuals
Shimizu Y, et al., J Vasc Dis (2023) |
| 2025.9.9 | Prevalence of human T-lymphotropic virus type I in patients with psoriasis and its effect on treatment choice: A multicenter observational study
Yonekura K, et al, J Dermatol Sci (2023) |
| 2025.9.9 | Performance evaluation of Espline HTLV-I/II, a newly developed rapid immunochromatographic antibody test for different diagnostic situations
Kuramitsu M, et al, Microbiol Spectr (2023) |
| 2025.9.9 | Current challenges facing the clinical treatment for HTLV-1 ocular manifestations
Kamoi K., Expert Rev Ophthalmol (2023) |
| 2025.9.9 | Outcomes in human T-cell leukemia virus type I carriers after hematopoietic stem cell transplantation for diseases other than adult T cell leukemia/lymphoma: a Japanese national survey
Nakano N,et al, Lancet Reg Health West Pac (2023) |
| 2025.9.9 | RAISING revealed a heterogenous pattern of HTLV-1 clonality after HLA-haploidentical peripheral blood stem cell transplantation for ATL
Itonaga H, et al., Leuk lymphoma (2023) |
| 2025.9.9 | Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma
Aikawa A, et al., Eur J Phamacol (2023) |
| 2025.9.9 | Clinical landscape of TP73 structural variants in ATL patients
Hiramatsu H, et al., Leukemia (2023) |
| 2025.9.9 | A case of acute kidney injury due to native kidney BK polyomavirus-associated nephropathy in a human T-lymphotropic virus type 1 carrier
Takae K, et al., BMC Nephrol (2023) |
| 2025.9.9 | Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review
Kimuara S, et al., Intern Med (2023) |
| 2025.9.9 | Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review
Nakahata S, et al., Biomolecules (2023) |
| 2025.9.9 | Measures for the Prevention of Mother-to-Child Human T-Cell Leukemia Virus Type 1 Transmission in Japan: The Burdens of HTLV-1-Infected Mothers
Uchimaru K and Itabashi K, Viruses (2023) |
| 2025.9.9 | Human T-cell Lymphotropic Virus Type-1-associated Bronchioloalveolar Disorder with Non-necrotizing Granulomas: A Case Report and Literature Review.
Kimura S, et al., Intern Med (2023) |
| 2025.9.9 | Impact of HLA-mismatched unrelated transplantation in patients with adult T-cell leukemia/lymphoma
Inoue Y, et al., Bone Marrow Transplant (2023) |
| 2025.9.9 | Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test.
Sagara Y, et. al., J Clin Virol (2023) |
| 2025.9.9 | Secondary Budd-Chiari syndrome caused by adult T-cell leukemia/lymphoma
Tominaga R, et al., Pathol Int (2023) |
| 2025.9.9 | Rapid T-cell lymphoma progression associated with immune checkpoint inhibitors
Ohmoto A, Fuji S, Expert Rev Hematol (2023) |
| 2025.9.9 | The clinical impact of the ratio of C-reactive protein to albumin (CAR) in patients with acute- and lymphoma-type adult T-cell leukemia-lymphoma (ATL)
Kawano N, et al., J Clin Exp Hematop (2023) |
| 2025.9.9 | Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
Kameda T, et al., Haematologica (2023) |
| 2025.9.9 | Lenalidomide treatment for recurrent adult T-cell leukemia/lymphoma after allogeneic hematopoietic cell transplantation
Tanaka T, et al., Hematol Oncol (2023) |
| 2025.9.9 | An update on the developments in the treatment of adult T-cell leukemia-lymphoma: current knowledge and future perspective
Makiyama J, et al., Jpn J Clin Oncol (2023) |
| 2025.9.9 | Peripheral T-Cell Lymphoma: From Biological Research to New Therapies.
Nakahata S, Morishita K., Cancers (Basel) (2023) |
| 2025.9.9 | Progression of adult T-cell leukemia/lymphoma from smoldering to acute type due to branched subclonal evolution
Jimbo K, et al., EJHaem (2023) |
| 2025.9.9 | Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphoma.
Oura M, et al., EJHaem (2023) |
| 2025.9.9 | HTLV-1 cell-free DNA in plasma as a potential biomarker in HTLV-1 carriers and adult T-cell leukemia-lymphoma.
Katsuya H, et al., EJHaem (2023) |
| 2025.9.9 | Profile of Nagasaki Islands Study (NaIS): A Population-Based Prospective Cohort Study on Multi-disease.
Miyata J, et al., J Epidemiol (2023) |
| 2025.9.9 | Progression of Carotid Intima-Media Thickness Partly Indicates the Prevention of Hypertension among Older Individuals in the General Population.
Shimizu Y., Life (Basel) (2023) |
| 2025.9.9 | Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.
Nakajima S, Okuma K., Int J Mol Sci (2023) |
| 2025.9.9 | Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization.
Fukuhara T, et al., Int J Mol Sci (2023) |
| 2025.9.9 | The unique activity of saponin: Induction of cytotoxicity in HTLV-1 infected cells.
Shida W, et al., Bioorg Med Chem (2023) |
| 2025.9.9 | EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy.
Koseki A, et al., Front Microbiol (2023) |
| 2025.9.9 | HTLV-1 Proliferation after CD8+ Cell Depletion by Monoclonal Anti-CD8 Antibody Administration in Latently HTLV-1-Infected Cynomolgus Macaques.
Nakamura-Hoshi M, et al., Microbiol Spectr (2023) |
| 2025.9.9 | Evaluation of human T-cell leukemia virus in vitro diagnostics using plasma specimens collected in Japan.
Kusagawa S, et al., BMC Infect Dis (2023) |
| 2025.9.9 | Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.
Kusuda M, et al., Br J Haematol (2023) |
| 2025.9.9 | The clinical benefit of acute GVHD depends on the age at transplantation in patients with adult T-cell leukemia-lymphoma on behalf of the ATL Working Group of the Japan Society for Transplantation and Cellular Therapy
Fuji S, et al., Bone Marrow Transplant (2023) |
| 2025.9.9 | Prospects of early therapeutic interventions for indolent adult T-cell leukemia/lymphoma based on the chronic lymphocytic leukemia progression model
Ohmoto A, Fuji S, Blood Rev (2023) |
| 2025.9.9 | Majocchi Granuloma in a Patient with Adult T-cell Leukemia
Ishibashi T, et al., Mycopathologia (2023) |
| 2025.9.9 | CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Nakashima M, Uchimaru K., Int J Mol Sci (2023) |
| 2025.9.9 | Screening of promising chemotherapeutic candidates from plants against human adult T-cell leukemia/lymphoma (VIII): six new withanolides from Physalis philadelphica.
Nakano D, et al., J Nat Med (2023) |
| 2025.9.9 | Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.
Ishikawa C, Mori N., Med Oncol (2023) |
| 2025.9.9 | HTLV-1 bZIP Factor-Induced Reprogramming of Lactate Metabolism and Epigenetic Status Promote Leukemic Cell Expansion.
Toyoda K, et al., Blood Cancer Discov (2023) |
| 2025.9.9 | HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report.
Matsuura E, et al., BMC Musculoskelet Disord (2023) |
| 2025.9.9 | Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Matsuura E, et al., Pathogens (2023) |
| 2025.9.9 | How Can We Prevent Mother-to-Child Transmission of HTLV-1?
Itabashi K, Miyazawa T, Uchimaru K., Int J Mol Sci (2023) |
| 2025.9.9 | Primary Effusion Lymphoma-like ATL Developing during Hemodialysis.
Masaki M, et al., Intern Med (2023) |
| 2025.9.9 | Adult T-cell leukemia/lymphoma presenting with ulceration of the digits
Fujii K, et al., J Dermatol (2023) |
| 2025.9.9 | T cell lymphoma: time to make discoveries and advance treatment
Ishitsuka K, Int J Hematol (2023) |
| 2025.9.9 | Shikonin Induces ROS-Dependent Apoptosis Via Mitochondria Depolarization and ER Stress in Adult T Cell Leukemia/Lymphoma
Boonnate P, Kariya R, Okada S, Antioxidants (Basel) (2023) |
| 2025.9.9 | Cord blood is a suitable donor source of allogeneic hematopoietic cell transplantation for adult T-cell leukemia-lymphoma: a nationwide retrospective study
Tokunaga M, et al., Bone Marrow Transplant (2023) |
| 2025.9.9 | Prognostic indices for peripheral T-cell lymphoma - not otherwise specified and adult T-cell leukemia/lymphoma: From past to future
Ishitsuka K, J Clin Exp Hematop (2023) |
| 2025.9.9 | An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
Izutsu K, et al., Blood (2023) |
| 2025.9.9 | ANK Therapeutic Prospects and Usefulness of PD-L1 and NK Activity as Biomarkers for Predicting Treatment Efficacy Revealed from the Treatment Course of Patients with HTLV-1-Associated Bronchioloalveolar Disease
Nagai K, et al., Cancer Med J (2023) |
| 2025.9.9 | HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity
Ohmoto A, et al., Expert Rev Anti Infect Ther (2023) |
| 2025.9.9 | Adult T-cell leukemia/lymphoma complicated by Pneumocystis pneumonia in a non-endemic area
Kunimoto M, et al., Respir Med Case Rep (2023) |
| 2025.9.9 | Safety of intraocular anti-VEGF antibody treatment under in vitro HTLV-1 infection
Zong Y, et al., Front Immunol (2023) |
| 2025.9.9 | Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease
Nozuma S, et al., Ann Clin Transl Neurol (2023) |
| 2025.9.9 | Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations
Mochida K, et al., J Dermatol Sci (2023) |
| 2025.9.9 | A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report
Nagahori T, et al., BMC Neurol (2023) |
| 2025.9.9 | HAS-Flow May Be an Adequate Method for Evaluating Human T-Cell Leukemia Virus Type 1 Infected Cells in Human T-Cell Leukemia Virus Type 1-Positive Rheumatoid Arthritis Patients Receiving Antirheumatic Therapies: A Retrospective Cross-Sectional Observation Study
Umekita K, et al., Viruses (2023) |
| 2025.9.9 | Human T-cell Leukemia Virus Type 1 (HTLV-1)-induced Uveitis
Terada Y, et al., Ocul Immunol Inflamm (2023) |
| 2025.9.9 | Cost-effectiveness of human T-cell leukemia virus type 1 (HTLV-1) antenatal screening for prevention of mother-to-child transmission
Kowada A, et al., PLoS Negl Trop Dis (2023) |
| 2025.9.9 | A case of Strongyloides hyperinfection syndrome with elevated IgG4
Takao R, et al., IDCases (2023) |
| 2025.9.9 | HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
Nakamura T., Pathogens (2023) |
| 2025.9.9 | Factors Influencing the Indeterminate Results in a T-SPOT.TB test: A Matched Case-control Study
Herai Y, et al., Intern Med (2023) |
| 2025.9.9 | Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study
Imaizumi Y, et al., Int J Hematol (2023) |
| 2025.9.9 | Successful Treatment of an Aggressive Adult T-cell Leukemia/Lymphoma with Strong CD30 Expression Using Brentuximab Vedotin as Combination and Maintenance Therapy
Baba Y, et al., Intern Med (2023) |
| 2025.9.9 | Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study
Hirosawa M, et al., Int J Hematol (2023) |
| 2025.9.9 | Viral, genetic, and immune factors in the oncogenesis of adult T-cell leukemia/lymphoma
Yasunaga JI, Int J Hematol (2023) |
| 2025.9.9 | A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan
Owatari S, et al., Leuk Lymphoma (2023) |
| 2025.9.9 | Current and emerging therapeutic strategies in adult T-cell leukemia-lymphoma
Katsuya H, Int J Hematol (2023) |
| 2025.9.9 | Severe mitral regurgitation in chronic adult T-cell leukemia/lymphoma with granulomatous valvular inflammation
Sunagawa G, et al., J Cardiol Cases (2023) |
| 2025.9.9 | CD30 stimulation induces multinucleation and chromosomal instability in HTLV-1-infected cell lines
Watanabe M, et al., Int J Hematol (2023) |
| 2025.9.9 | Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy
Sato T, et al., Brain (2023) |
| 2025.9.9 | Awareness of Infectious Disease Screening During Early Pregnancy and Knowledge About its Vertical Transmission in Japan: A Report from the Pregnant Women Health Initiative
Odagami M, et al., Matern Child Health J (2023) |
| 2025.9.9 | Dimethyl Fumarate Suppresses the Proliferation of HTLV-1-infected T Cells by Inhibiting CBM Complex-triggered NF-kB Signaling
Sato T, et al., Anticancer Res (2023) |
| 2025.9.9 | HTLV-1 bZIP factor impairs DNA mismatch repair system
Sakurada-Aono M, et al., Biochem Biophys Res Commun (2023) |
| 2025.9.9 | HTLV-1-associated demyelinating neuropathy: A case report and review of the literature
Tamaki K, et al., eNeurologicalSci (2023)
|
2023.10.2
論文解説 |
Vaccination with short-term-cultured autologous PBMCs efficiently activated STLV-1-specific CTLs in naturally STLV-1-infected Japanese monkeys with impaired CTL responses.
Hasegawa A, et. al., PLoS Pathog (2023) |
2025.4.16
論文解説 |
Identification and tracking of HTLV-1-infected T cell clones in virus-associated neurologic disease
Nozuma S, JCI Insight (2023) |
2023.10.2
論文解説
|
The Association of Increase of Human T-Cell Leukemia Virus Type-1 (HTLV-1) Proviral Load (PVL) With Infection in HTLV-1-Positive Patients With Rheumatoid Arthritis: A Longitudinal Analysis of Changes in HTLV-1 PVLs in a Single Center Cohort Study.
Iwamoto N, et. al., Front Immunol (2022) |
2023.10.2
論文解説 |
Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan.
Sagara Y, et. al., J Clin Virol (2022) |
2023.10.2
論文解説 |
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
Kameda T, et. al., Commun Biol (2022) |
2023.10.2
論文解説 |
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.
Kurahashi Y, et. al., Blood Adv (2022) |
2025.4.16
論文解説 |
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma
Nakashima M, et al. Cancer Science (2022) |
2023.10.2
論文解説 |
Epidemiology of adult T-cell leukemia-lymphoma in Japan: An updated analysis, 2012-2013.
Ito S, et. al., Cancer Sci (2021) |
2025.4.16
論文解説 |
Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
Jo T, et al. Cancer Immunology, Immunotherapy (2023) |
2025.4.16
論文解説 |
A Comprehensive Study of the Immunophenotype and its Clinicopathologic Significance in Adult T-cell Leukemia/Lymphoma
Tamaki T, et al. Modern Pathology (2023) |
2025.4.16
論文解説 |
Lower prevalence of anti-HTLV-1 as expected by previous models among first-time blood donors in Japan
Satake M, et. al., Journal of Medical Virology (2023) |
2023.10.2
論文解説 |
RAISING is a high-performance method for identifying random transgene integration sites.
Wada Y, et. al., Commun Biol (2022) |
2023.10.2
論文解説 |
Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.
Matsuo M, et. al., Nat Commun (2022) |
2023.10.2
論文解説 |
M-Sec induced by HTLV-1 mediates an efficient viral transmission.
Hiyoshi M, et. al., PLoS Pathog (2021) |
2023.10.2
論文解説 |
Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
Tanaka Y, et. al., Front Immunol (2022) |
2024.9.30
論文解説 |
Mechanisms of action and resistance in histone methylation-targeted therapy.
Yamagishi M, et. al., Nature (2024) |
2024.9.30
論文解説 |
Mortality and risk of progression to adult T-cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M, et al., Proc Natl Acad Sci USA (2020) |
| 2023.10.2 | Establishment of a Cynomolgus Macaque Model of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Direct Inoculation of Adult T-Cell Leukemia Patient- Derived Cell Lines for HTLV-1 Infection.
Urano E, et. al., J Virol (2022) |
| 2023.10.2 | Frequency of HTLV-1 seroconversion between pregnancies in Nagasaki, Japan, 2011-2018.
Komatsu N, et. al., Front Microbiol (2022) |
| 2023.10.2 | Cytolytic Recombinant Vesicular Stomatitis Viruses Expressing STLV-1 Receptor Specifically Eliminate STLV-1 Env-Expressing Cells in an HTLV-1 Surrogate Model In Vitro.
Seki Y, et. al., Viruses (2022) |
| 2023.10.2 | HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision.
Kamoi K, et. al., Lancet (2022) |
| 2023.10.2 | Recent Prevalence of Human T-cell Leukemia Virus Type 1 Carrier Associated with Horizontal Transmission in Pregnant Japanese Women.
Suzuki S, et. al., Jpn J Infect Dis (2021) |
| 2023.10.2 | Mother-to-Child Transmission of Human T-Cell Leukemia Virus Type 1: Mechanisms and Nutritional Strategies for Prevention.
Itabashi K, Miyazawa T., Cancers (Basel) (2021) |
| 2023.10.2 | Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma.
Yamagishi M, et. al., Nat Commun (2021) |
| 2023.10.2 | The Effect of Early Postnatal Nutrition on Human T Cell Leukemia Virus Type 1 Mother-to-Child Transmission: A Systematic Review and Meta-Analysis.
Miyazawa T, et. al., Viruses (2021) |
2023.10.2
論文解説 | Human retroviral antisense mRNAs are retained in the nuclei of infected cells for viral persistence.
Ma G, et. al., Proc Natl Acad Sci U S A (2021) |
2023.10.2
論文解説 | Anti-Human T-Cell Leukemia Virus Type 1 (HTLV-1) Antibody Assays in Cerebrospinal Fluid for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Kodama D, et. al., J Clin Microbiol (2021) |
2023.10.2
論文解説 | Horizontal transmission of HTLV-1 causing uveitis.
Kamoi K, et. al., Lancet Infect Dis (2021) |
| 2023.10.2 | Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population.
Penova M, et. al., Proc Natl Acad Sci U S A (2021) |
| 2023.10.2 | Human T-Cell Leukemia Virus Type 1 Infection Is a Risk Factor for Atherosclerosis.
Takeoka H, et. al., J Clin Med Res (2021) |
2023.10.2
論文解説 | Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains.
Sakihama S, et. al., Cancer Sci (2021) |
2023.10.2
論文解説 | In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
Izaki M, et. al., PLoS Pathog (2021) |
| 2023.10.2 | Estimation of the window period of human T-cell leukemia virus type 1and 2 tests by a lookback study of seroconverters among Japanese voluntary blood donors.
Sagara Y, et. al., Transfusion (2021) |
| 2023.10.2 | Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.
Nakahata S, et. al., Haematologica (2021) |
| 2023.10.2 | Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1-infected Hodgkin and Reed-Sternberg-like cells.
Karube K, et. al., Blood Adv (2021) |
2023.10.2
論文解説 | Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Imaizumi Y, et. al., Cancer Sci (2020) |
2023.10.2
論文解説 | Tackling HTLV-1 infection in ophthalmology: a nationwide survey of ophthalmic care in an endemic country, Japan.
Kamoi K, et. al., Br J Ophthalmol (2020) |
2023.10.2
論文解説 | HTLV-1 targets human placental trophoblasts in seropositive pregnant women.
Tezuka K, et. al., J Clin Invest (2020) |
| 2023.10.2 | Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.
Okuma K, et. al., Retrovirology (2020) |
| 2023.10.2 | Implementation of nationwide screening of pregnant women for HTLV-1 infection in Japan: analysis of a repeated cross-sectional study.
Yonemoto N, et. al., BMC Public Health (2020) |
| 2023.10.2 | Hodgkin and Reed-Sternberg-like cells infected with human T-cell leukemia virus type 1.
Tsuruta Y, Karube K., Blood (2020) |
| 2023.10.2 | Frequent horizontal and mother-to-child transmission may contribute to high prevalence of STLV-1 infection in Japanese macaques.
Murata M, et. al., Retrovirology (2020) |
| 2023.10.2 | HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.
Higuchi Y, et. al., Proc Natl Acad Sci U S A. (2020) |
| 2023.10.2 | Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nagasaka M, et. al., Proc Natl Acad Sci U S A (2020) |
| 2023.10.2 | Activation of PERK-ATF4-CHOP pathway as a novel therapeutic approach for efficient elimination of HTLV-1-infected cells.
Ikebe E, et. al., Blood Adv (2020) |
| 2023.10.2 | A Nationwide Antenatal Human T-Cell Leukemia Virus Type-1 Antibody Screening in Japan.
Itabashi K, et. al., Front Microbiol (2020) |
2023.10.2
論文解説 | Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATL.
Guerrero CLH, et. al., Blood Adv (2020) |
| 2023.3.24 |
Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan
Satake M, Sagara Y, Hamaguchi I, Journal of Medical Virology (2023) |
2020.10.19
論文解説 |
Frosted branch angiitis after allogeneic haematopoieticstem cell transplantation in adult T-cell leukaemia-lymphoma
成人T細胞白血病における同種造血幹細胞移植後に起こる樹氷状網膜血管炎
Kamoi K, et al., THE LANCET Haematology (2020) |
2020.9.11
論文解説 |
Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.
ウエスタンブロット法の代替法としてのラインブロット法を用いたヒトT細胞白血病ウイルス１型感染の新規診断検査アルゴリズムの確立：日本における診断検査性能評価のための共同研究
Kazu Okuma, et al., Retrovirology (2020) |
2019.1.18
論文解説 |
Development of reference material with assigned value for human T-cell leukemia virus type 1 quantitative PCR in Japan
HTLV-1定量PCRの参照品の開発
Kuramitsu M. et al. Microbiology and Immunology (2018) |
2018.3.15
論文解説 |
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.
HTLV-1関連脊髄症におけるモガムリズマブ（抗CCR4抗体）
Sato T, et al., N Engl J Med. (2018) |
2016.12.1
論文解説 |
Dysregulation of c-Myb pathway by aberrant expression of proto-oncogene MYB provides the basis for malignancy in adult T-cell leukemia/lymphoma cells
Proto-oncogene MYB遺伝子発現異常によるc-Myb経路撹乱がATL細胞悪性化形質を規定する
Nakano K, et al., Clinical Cancer Research (2016) |
2016.11.25
論文解説 |
Incidence of human T-lymphotropic virus 1 infection in adolescent and adult blood donors in Japan: a nationwide retrospective cohort analysis.
日本の青年期・成人献血者における新規HTLV-1感染の実態
Satake M, et al., Lancet Infectious Disease (2016) |
2016.5.30
論文解説 |
CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
ATLLにおけるCCR4変異に基づく臨床病理解析
Yoshida N, et al., The Journal of Pathology (2016) |
2016.5.30
論文解説 |
Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study.
HTLV-1核酸定量の標準化：多施設共同研究
Madoka Kuramitsu, et al., Journal of Clinical Microbiology (2015) |
2016.5.12
論文解説 |
Treatment and survival among 1594 patients with ATL.
2000年以降に診断されたATL患者の治療実態と予後
Katsuya H, et al., Blood (2016) |
2016.5.12
論文解説 |
The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome
HTLV-1によるヒトゲノムへの異所性CTCF結合部位挿入
Satou Y, et al., Proc Natl Acad Sci U S A (2016) |
2016.5.6
論文解説 |
Polycomb-dependent epigenetic landscape in adult T-cell leukemia
ATL細胞のエピゲノム異常の実態
Fujikawa D, et al., Blood (2016) |
2015.10.28
論文解説 |
Integrated molecular analysis of adult T-cell leukemia/lymphoma
ATLの包括的分子解析
Kataoka K, et al., Nature Genetics, (2015) |
